Lupin arm gets tentative FDA nod for anti-bacterial drug

Gavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news